OHI · Omega Healthcare Investors Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted FFO per diluted share non-GAAP | $0.83 | Q2 2026 | — |
| Adjusted Funds From Operations non-GAAP | $261M | Q2 2026 | — |
|
|
|||
| Common shares issued | 1.3M | Q2 2026 | — |
| FAD per diluted share non-GAAP | $0.78 | Q2 2026 | — |
|
|
|||
| Funds Available for Distribution non-GAAP | $248M | Q2 2026 | — |
|
|
|||
| Net Operating Income non-GAAP | $331M | Q2 2026 | — |
| New investments completed | $126M | Q2 2026 | — |
|
|
|||
| Quarterly common dividend | $0.68 | August 2026 | — |
| Saber facilities leased from Company | 69 | Q2 2026 | — |
| Saber JV contractual rent per annum | $83.1M | Q2 2026 | — |
| Saber JV number of facilities | 71 | Q2 2026 | — |
| Saber JV weighted average interest rate | 5.6% | Q2 2026 | — |
| Saber PropCo JV net investment activity | $124.3M | Q2 2026 | — |
| Weighted-average common shares outstanding | 316M | Q2 2026 | — |
| Adjusted Funds From Operations (full year) non-GAAP | $946M | FY 2025 | — |
| Aggregate debt repaid (Q4) | $1.27B | Q4 2025 | — |
| ATM Program size (new) | $2B | Q4 2025 | — |
| Delayed draw unsecured term loan facility drawn | $300M | Q4 2025 | — |
| FAD per diluted share (full year) non-GAAP | $2.96 | FY 2025 | — |
| Funds Available for Distribution (full year) non-GAAP | $903M | FY 2025 | — |
| New investments completed (full year) | $1.1B | FY 2025 | — |
| Omega OP Units issued (Q4) | 5.5M | Q4 2025 | — |
| Senior unsecured credit facility size (new) | $2.3B | FY 2025 | — |
| Value of Omega OP Units issued | $222M | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OHI
this stock
Omega Healthcare Investors Inc
|
$14.11B | +5.8% | +13.2% | 16.6 | 4.2% |
|
WELL
Welltower Inc.
|
$166.20B | +27.0% | +35.6% | 117.1 | 2.5% |
|
VTR
Ventas, Inc.
|
$46.78B | +18.7% | +18.5% | 168.9 | 4.6% |
|
DOC
Healthpeak Properties, Inc.
|
$14.24B | +29.1% | +4.5% | 59.0 | 3.5% |
|
AHR
American Healthcare REIT, Inc.
|
$11.86B | +17.3% | +9.1% | 78.9 | 10.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OHI | +2.3% | -7.3% | -2.4% | -7.3% | +5.8% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +2.7% | -10.2% | -14.0% | -10.3% | -7.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.